Filter Results :

Your search for therapies returned 89 reports

Sort by


Global Ophthalmology Drugs Market to 2022 - Angiogenesis Modulators and Gene Therapies to Boost Overall Revenue within the Forecast Period

01 Aug 2016  |  Published by:  GBI Research
SummaryOphthalmology is a therapy area that deals with the diagnosis, treatment and prevention of diseases associated with the eyes and visual system. Most eye disorders occur over a long period of time, and are initially asymptomatic or cause only a slight decrease in vision. Howeve...

$ 4,995.00

Read More

Frontier Pharma: Chronic, Acute and Neuropathic Pain - GPCR and Nerve Growth Factor-based therapies offer strong potential in difficult-to-treat subtypes

01 Aug 2016  |  Published by:  GBI Research
SummaryPain, and in particular chronic pain, is a significant global health issue. While pain is not considered a disease in its own right, there is a growing body of evidence that substantiates chronic pain as a disease, rather than just as a symptom of a primary cause. In the US, p...

$ 6,995.00

Read More

Global Respiratory Drugs Market to 2022 - Pipeline and Market Characterized by Growing Prominence of Targeted Therapies, with Asthma and Cystic Fibrosis Leading the Way

01 Aug 2016  |  Published by:  GBI Research
SummaryThe respiratory therapy area consists of indications that affect the respiratory system in different ways, such as the scarring of lung tissue, and excessive production of mucus in the airways, thereby decreasing lung function. Some of the key indications in this therapy area ...

$ 4,995.00

Read More

Type 2 Diabetes Mellitus Therapeutics in South-East Asia Markets to 2022 - Increasing Usage of Newer Therapies and Expanding Treatment Population to Encourage Robust Growth

01 Aug 2016  |  Published by:  GBI Research
SummaryDiabetes mellitus is a group of metabolic diseases characterized by chronic hyperglycemia - high blood glucose levels - that results from defects in insulin secretion, insulin action, or a combination of these. This chronic hyperglycemia is associated with long-term damage, dy...

$ 4,995.00

Read More

Therapies for Rheumatoid Arthritis: Technologies and Global Markets

26 Jul 2016  |  Published by:  BCC Research-JT Gabrielsen Consulting LLC Research
The global market for therapies for rheumatoid arthritis reached $19.0 billion in 2014. The market is expected to reach nearly $21.3 billion by 2020 from $19.9 billion in 2015, increasing at a compound annual growth rate (CAGR) of 1.3% from 2015 to 2020. This report provides: -An overvie...

$ 6,650.00

Read More

Osteoporosis Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Anabolic Therapies

04 Jul 2016  |  Published by:  GBI Research
SummaryOsteoporosis, the most common metabolic bone disease, is characterized by low bone mass, microarchitectural deterioration of bone tissue, and a consequent increase in fracture risk. Osteoporosis is generally known as an asymptomatic disease, as there are no visible signs until...

$ 4,995.00

Read More

Stem Cell Therapies - Global Trends in the Competitive, Technological and R&D Landscape

01 Jul 2016  |  Published by:  GBI Research
SummaryGBI Research’s latest report, "Stem Cell Therapies - Global Trends in the Competitive, Technological and R&D Landscape" provides an in-depth assessment of the current trends in the global stem cell therapy sector with a particular focus on the technological, competitive an...

$ 2,995.00

Read More

Global Allergy Immunotherapies Market 2016-2020

01 Jul 2016  |  Published by:  Technavio-Infiniti Research
About the Allergy Immunotherapies Market Immunotherapy, often referred to as desensitization, is the closest thing to a cure for allergic diseases and is an established treatment for severe allergies such as allergic rhinitis and allergic asthma. Its administration includes increasing the d...

$ 2,500.00

Read More

Global Stem Cell Therapies Market Research Report 2016

29 Jun 2016  |  Published by:  9Dimen Research
2016 Global Stem Cell Therapies Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Stem Cell Therapies industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and ...

$ 2,850.00

Read More

Renal Disease Treatments: Products and Therapies

23 Jun 2016  |  Published by:  BCC Research-JT Gabrielsen Consulting LLC Research
The U.S. market for kidney failure treatment will grow from $39.4 billion in 2016 to nearly $45.6 billion by 2021, with a compound annual growth rate (CAGR) of 3.0% for the period of 2016-2021. This report provides: -An in-depth analysis of the market for kidney failure treatment products ...

$ 6,650.00

Read More

Global Urological Cancer Market to 2022 - Strong Growth Driven by Rising Prevalence, Increased Uptake of Hormone Therapies and Approval of Novel Biologics

16 Jun 2016  |  Published by:  GBI Research
SummaryUrological cancers are thought to account for 19.5% of global cancer prevalence, with kidney, prostate, testicular and bladder cancer – the key indications covered in this report – accounting for the majority of that figure. Urological cancers affect the male and female urinar...

$ 4,995.00

Read More

Frontier Pharma: Hematological Cancers - Highly Innovative Pipeline Continues Trend towards Targeted, Patient-Specific Therapies

01 Jun 2016  |  Published by:  GBI Research
Summary Hematological malignancies are a class of cancer that affect the blood, lymph nodes and bone marrow, and include numerous forms of leukemia, lymphoma and myeloma. Hematological malignancies constituted 9% of all newly diagnosed malignancies in the US in 2011, with data indicating th...

$ 6,995.00

Read More

Frontier Pharma: Diabetic Complications - Innovative and Diverse Neuropathies, Nephropathy and Retinopathies Pipelines Demonstrate Shift Towards Disease Modifying Therapies

01 Jun 2016  |  Published by:  GBI Research
SummaryDiabetes is a common long-term condition that can lead to a range of disparate and serious complications. It is a lifelong, multi-systemic condition that affects a number of integral organs. Diabetes has a rapidly increasing prevalence – it currently affects 10% of adults globally...

$ 6,995.00

Read More

Obesity Drugs and Therapies: Technologies and Global Markets

18 May 2016  |  Published by:  BCC Research-JT Gabrielsen Consulting LLC Research
The global market for obesity treatments should reach over $7.8 billion by 2021 from over $4.3 billion in 2016 at a compound annual growth rate (CAGR) of 12.7% from 2016 to 2021. This report provides: -An overview of the global markets for obesity drugs, therapies, and related technologi...

$ 6,650.00

Read More

Non-Small Cell Lung Cancer Therapeutics in Asia-Pacific Markets to 2022 - Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market

01 May 2016  |  Published by:  GBI Research
SummaryNon-Small Cell Lung Cancer (NSCLC) is the most common cancer and cause of cancer-related mortality globally. There were more than 1.8 million newly diagnosed lung cancer cases in 2012 globally, accounting for 13% of the total number of cancer cases. Over half of the incident c...

$ 4,995.00

Read More
Total 89 records.